Reata Pharmaceuticals soars as the FDA asks for a preliminary drug application meeting for one of its treatments, instead of a more general type of meeting.

Here are the biotech stocks to buy that we think will see magnified growth over the coming year. Real Money writer Bret Jensen reveals his top picks.

J&J Snack Foods, Reata Pharmaceuticals, Cinemark Holdings, Blucora and Yelp are five top stock gainers for Monday.

Reata Pharmaceuticals says testing for its treatment could be delayed indefinitely.

Reata Pharmaceuticals soars Friday on rumors the company could be targeted by Amgen.

U.S. stock futures rise as investors prep for a two-day wave of bank earnings; Citigroup, JPMorgan Chase, Wells Fargo and Goldman Sachs report earnings Tuesday; the UAW plans a call Thursday to update striking workers on the status of talks with General Motors.

Stock gains in after-hours trading after phase II test results meet primary endpoint for a treatment of a rare genetic disease.

What the charts say.

Reata Pharmaceuticals had coverage initiated with a 'buy' rating.

The online retail giant had a plan to own your living room. It didn't work because AI-powered voice assistants don't work.

Online scams are more widespread than ever. Here's how to avoid them.

Tesla's competitors have made progress in cutting the EV leader's market share.